AbbVie's Q1 2026 dividend increases 5.5% YOY, lagging both its past growth rates and the healthcare sector median. Learn more about ABBV stock here.

These stocks offer yields of more than double the S&P 500 average.

The decision about buying these dividend stocks is an easy one.

Income investors can rely on these stocks.

These stocks sport dividend yields ranging from 2.9% to 5.5%.

I last wrote on AbbVie (ABBV) and Pfizer (PFE) on Sept 16 and Sept 18, respectively. My last ABBV article was titled “AbbVie: Best Time To Sell In 5 Years,” and the PFE article was titled “Pfizer: ...

AbbVie raised its dividend for 13 straight years with a 13% CAGR over the past decade. The current yield stands at 2.9%. Skyrizi and Rinvoq are projected to reach $31B in combined sales by 2027. The ...

AbbVie (ABBV) is up 36% year-to-date and 187% over the last five years. AbbVie pays a $6.92 annual dividend with a 2.96% yield. Realty Income offers a 5.64% dividend yield and has raised its dividend ...

This healthcare giant is a top pick for growth and dividend investors.

AbbVie's board has raised the quarterly dividend by 5.5%, to $1.73 from $1.64, extending the biopharmaceutical company's royal payout status. The new quarterly rate, equal to $6.92 a year, represents ...

AbbVie’s recent performance and what it might mean for investors AbbVie (ABBV) has seen its share price record a 1 day return ...